Related references
Note: Only part of the references are listed.Drug testing in Europe: monitoring results of the Trans European Drug Information (TEDI) project
Tibor M. Brunt et al.
DRUG TESTING AND ANALYSIS (2017)
Purity, adulteration and price of drugs bought on-line versus off-line in the Netherlands
Daan van der Gouwe et al.
ADDICTION (2017)
Crystals and tablets in the Spanish ecstasy market 2000-2014: Are they the same or different in terms of purity and adulteration?
Claudio Vidal Gine et al.
FORENSIC SCIENCE INTERNATIONAL (2016)
Meta-analysis of molecular imaging of serotonin transporters in ecstasy/polydrug users
Carl. Alexander Roberts et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2016)
Risk of emergency medical treatment following consumption of cannabis or synthetic cannabinoids in a large global sample
Adam Winstock et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2015)
Harms from other people's drinking: an international survey of their occurrence, impacts on feeling safe and legislation relating to their control
Mark A. Bellis et al.
BMJ OPEN (2015)
Use of Silk Road, the online drug marketplace, in the United Kingdom, Australia and the United States
Monica J. Barratt et al.
ADDICTION (2014)
In abstinent MDMA users the cortisol awakening response is off-set but associated with prefrontal serotonin transporter binding as in non-users
Vibe Gedsoe Frokjaer et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2014)
Effects of MDMA and Intranasal Oxytocin on Social and Emotional Processing
Matthew G. Kirkpatrick et al.
NEUROPSYCHOPHARMACOLOGY (2014)
MDMA effects consistent across laboratories
Matthew G. Kirkpatrick et al.
PSYCHOPHARMACOLOGY (2014)
MDMA enhances emotional empathy and prosocial behavior
Cedric M. Hysek et al.
SOCIAL COGNITIVE AND AFFECTIVE NEUROSCIENCE (2014)
The Potential Dangers of Using MDMA for Psychotherapy
Andrew C. Parrott
JOURNAL OF PSYCHOACTIVE DRUGS (2014)
Pharmacological characterization of designer cathinones in vitro
L. D. Simmler et al.
BRITISH JOURNAL OF PHARMACOLOGY (2013)
Durability of improvement in post-traumatic stress disorder symptoms and absence of harmful effects or drug dependency after 3,4-methylenedioxymethamphetamine-assisted psychotherapy: a prospective long-term follow-up study
Michael C. Mithoefer et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2013)
A randomized, controlled pilot study of MDMA (+/- 3,4-Methylenedioxymethamphetamine)-assisted psychotherapy for treatment of resistant, chronic Post-Traumatic Stress Disorder (PTSD)
Peter Oehen et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2013)
MDMA, serotonergic neurotoxicity, and the diverse functional deficits of recreational 'Ecstasy' users
Andrew C. Parrott
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2013)
Mapping serotonergic dysfunction in MDMA (ecstasy) users using pharmacological MRI
M. L. J. Schouw et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2012)
Pharmacogenetic studies of change in cortisol on ecstasy (MDMA) consumption
Kim Wolff et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2012)
Sustained Recreational Use of Ecstasy Is Associated with Altered Pre and Postsynaptic Markers of Serotonin Transmission in Neocortical Areas: A PET Study with [11C]DASB and [11C]MDL 100907
Nina B. L. Urban et al.
NEUROPSYCHOPHARMACOLOGY (2012)
The Effects of Ecstasy (MDMA) on Brain Serotonin Transporters Are Dependent on Age-of-First Exposure in Recreational Users and Animals
Anne Klomp et al.
PLOS ONE (2012)
A direct comparison of the behavioral and physiological effects of methamphetamine and 3,4-methylenedioxymethamphetamine (MDMA) in humans
Matthew G. Kirkpatrick et al.
PSYCHOPHARMACOLOGY (2012)
Influence of different cellular environments on [3H]DASB radioligand binding
D. R. Quelch et al.
SYNAPSE (2012)
In Vivo Imaging of Cerebral Serotonin Transporter and Serotonin2A Receptor Binding in 3,4-Methylenedioxymethamphetamine (MDMA or Ecstasy) and Hallucinogen Users
David Erritzoe et al.
ARCHIVES OF GENERAL PSYCHIATRY (2011)
Variability in the 3,4-methylenedioxymethamphetamine content of 'ecstasy' tablets in the UK
David Michael Wood et al.
EMERGENCY MEDICINE JOURNAL (2011)
The safety and efficacy of ± 3,4-methylenedioxymethamphetamine-assisted psychotherapy in subjects with chronic, treatment-resistant posttraumatic stress disorder: the first randomized controlled pilot study
Michael C. Mithoefer et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2011)
Is Ecstasy an Empathogen? Effects of ±3,4-Methylenedioxymethamphetamine on Prosocial Feelings and Identification of Emotional States in Others
Gillinder Bedi et al.
BIOLOGICAL PSYCHIATRY (2010)
Decreased cerebral cortical serotonin transporter binding in ecstasy users: a positron emission tomography/[11C]DASB and structural brain imaging study
Stephen J. Kish et al.
BRAIN (2010)
Brain serotonin transporter binding in former users of MDMA ('ecstasy')
Sudhakar Selvaraj et al.
BRITISH JOURNAL OF PSYCHIATRY (2009)
Sustained effects of ecstasy on the human brain: a prospective neuroimaging study in novel users
Maartje M. L. de Win et al.
BRAIN (2008)
Dance clubbing on MDMA and during abstinence from Ecstasy/MDMA: Prospective neuroendocrine and psychobiological changes
A. C. Parrott et al.
NEUROPSYCHOBIOLOGY (2008)
A role for oxytocin and 5-HT1A receptors in the prosocial effects of 3,4-methylenedioxymethamphetamine (ecstasy)
M. R. Thompson et al.
NEUROSCIENCE (2007)
Neuroimaging research in human MDMA users: a review
Ronald L. Cowan
PSYCHOPHARMACOLOGY (2007)
Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users: the longitudinal perspective
R Thomasius et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2006)
Neuroimaging findings with MDMA/ecstasy: technical aspects, conceptual issues and future prospects
L Reneman et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2006)
Quantitative PET studies of the serotonin transporter in MDMA users and controls using [11C]McN5652 and [11C]DASB
UD McCann et al.
NEUROPSYCHOPHARMACOLOGY (2005)
Chronic tolerance to recreational MDMA (3,4-methylenedioxymethamphetamine) or Ecstasy
AC Parrott
JOURNAL OF PSYCHOPHARMACOLOGY (2005)
Effect of ambient temperature and a prior neurotoxic dose of 3,4-methylenedioxymethamphetamine (MDMA) on the hyperthermic response of rats to a single or repeated ('binge' ingestion) low dose of MDMA
AR Green et al.
PSYCHOPHARMACOLOGY (2004)
Acute and long-term effects of MDMA on cerebral dopamine biochemistry and function
MI Colado et al.
PSYCHOPHARMACOLOGY (2004)
A voxel-based PET investigation of the long-term effects of Ecstasy consumption on brain serotonin transporters
R Buchert et al.
AMERICAN JOURNAL OF PSYCHIATRY (2004)
Acute, sub-acute and long-term subjective consequences of 'ecstasy' (MDMA) consumption in 430 regular users
SL Verheyden et al.
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL (2003)
Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users
R Thomasius et al.
PSYCHOPHARMACOLOGY (2003)
Effects of dose, sex, and long-term abstention from use on toxic effects of MDMA (ecstasy) on brain serotonin neurons
L Reneman et al.
LANCET (2001)
Cortical serotonin transporter density and verbal memory in individuals who stopped using 3,4-methylenedioxymethamphetamine (MDMA or ecstasy) - Preliminary findings
L Reneman et al.
ARCHIVES OF GENERAL PSYCHIATRY (2001)
Share Paper
